Lorenzo Alonso-Carrión

Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

Josep M. Piulats, Enrique Espinosa, Luis de la Cruz‐Merino et al. · Journal of Clinical Oncology · 2021 · 245 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

Salvador Martín‐Algarra, Enrique Espinosa, Jordi Rubió‐Casadevall et al. · European Journal of Cancer · 2009 · 85 citations

Medicine, Dermatology, Oncology +14

Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer

Alfonso Sánchez‐Muñoz, César Mendiola, Elísabeth Pérez-Ruiz et al. · Oncology · 2010 · 54 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Phase II multicenter, single arm, open label study of nivolumab (NIVO) in combination with ipilimumab (IPI) as first line in adult patients (pts) with metastatic uveal melanoma (MUM): GEM1402 NCT02626962.

Josep M. Piulats, Luis de la Cruz‐Merino, María Teresa Curiel García et al. · Journal of Clinical Oncology · 2017 · 15 citations

Medicine, Oncology, Pharmacotherapy +17

Cisplatin-Based Radiochemotherapy Improves the Negative Prognosis of c-erbB-2 Overexpressing Advanced Cervical Cancer

J. Pérez-Regadera, Alfonso Sánchez‐Muñoz, Claudio Ballestı́n et al. · International Journal of Gynecological Cancer · 2010 · 10 citations

Medicine, Oncology, Radiation Oncology +15